Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience

BACKGROUND: Adult medulloblastoma (MB) is rare, and management guidelines are largely based on pediatric clinical trials and retrospective series. Limited data exist with respect to clinical characteristics, prognostic factors, and outcomes based on first-line treatments. METHODS: Two hundred adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Majd, Nazanin K, Mastall, Maximilan, Lin, Heather, Dibaj, Seyede Shiva, Hess, Kenneth R, Yuan, Ying, Garcia, Manuela Martin-Bejarano, Fuller, Gregory N, Alfaro, Kristin D, Gule-Monroe, Maria K, Huse, Jason T, Khatua, Soumen, Rao, Ganesh, Sandberg, David I, Wefel, Jeffrey S, Yeboa, Debra N, Paulino, Arnold C, McGovern, Susan L, Zaky, Wafik, Mahajan, Anita, Suki, Dima, Weathers, Shiao-Pei, Harriso, Rebecca A, De Groo, John F, Puduvalli, Vinay K, Penas-Prado, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350154/
https://www.ncbi.nlm.nih.gov/pubmed/34377987
http://dx.doi.org/10.1093/noajnl/vdab079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350154/
https://www.ncbi.nlm.nih.gov/pubmed/34377987
http://dx.doi.org/10.1093/noajnl/vdab079

Ejemplares similares